Loading...
01/11 03:31
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a decline in key financial metrics like gross margins, operating income, and EPS, with additional currency headwinds and increased expenses. Although management provides optimistic guidance for future recovery, the Q&A section indicates skepticism about margin improvements and the impact of the Fem Care sale. The strategic plan's focus on debt reduction and brand investments doesn't alleviate immediate financial pressures. Given the market cap of ~$2 billion, the negative sentiment is likely to result in a stock price decline of -2% to -8% over the next two weeks.
The earnings call reveals declining financial metrics, including a 4.2% drop in organic net sales and a significant decrease in operating income and earnings per share. The Q&A section highlights concerns about cash flow, reliance on international growth, and lack of clear guidance for fiscal '26. Despite some positive developments, such as balanced inventory levels and international growth, the overall sentiment is negative due to the weak financial performance and vague future outlook. Given the company's small market cap, this could lead to a stock price decline of -2% to -8%.
The earnings call presents a mixed picture: International growth and increased gross margin are positives, but North American sales declined, operating income decreased, and consumer confidence is low. The Q&A reveals management's confidence in future growth, but uncertainties remain with tariffs and economic factors. The market cap suggests moderate volatility. Overall, the positives and negatives balance out, suggesting a neutral sentiment with potential for slight positive movement if international growth and strategic investments yield results.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
